Religare Enterprises has entered into definitive agreements on 06 February 2020 with Kedaara Capital Fund II LLP and Trishikhar Ventures LLP (jointly referred as 'Kedaara' ) for:
a) sale of part of the investment in Religare Health Insurance Company ('RHICL'), a subsidiary company for a consideration aggregating to Rs 200 crore, and
b) primary capital infusion of Rs 200 crore in RHICL by Kedaara
Pursuant to the above transactions, the Company would have divested part of its investment constituting 6.761% of RHICL. Post consummation of the transaction, the Company will hold 76.18% stake in RHICL.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
